{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:50:55Z","timestamp":1782773455552,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.clinre.2021.101714","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T14:37:22Z","timestamp":1619534242000},"page":"101714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4534-7991","authenticated-orcid":false,"given":"Ekaterina A.","family":"Nabatchikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzhamal T.","family":"Abdurakhmanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teona P.","family":"Rozina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Nikulkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena L.","family":"Tanaschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Moiseev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2021.101714_bib0005","series-title":"Global hepatitis report","first-page":"1","author":"WHO","year":"2017"},{"issue":"3","key":"10.1016\/j.clinre.2021.101714_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.20953\/1729-9225-2018-3-37-45","article-title":"Hepatitis C and its outcomes in Russia: analysis of incidence, prevalence and mortality rates before the start of the programme of infection elimination","volume":"16","author":"Pimenov","year":"2018","journal-title":"Infekc Bolezni (Infect Dis)"},{"key":"10.1016\/j.clinre.2021.101714_bib0015","first-page":"21","article-title":"Zdravoohranenie v rossii","author":"Oksenojt","year":"2017","journal-title":"Statisticheskij Sbornik\/ Rosstat"},{"key":"10.1016\/j.clinre.2021.101714_bib0020","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/lt.21117","article-title":"A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation","volume":"13","author":"Yilmaz","year":"2007","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.clinre.2021.101714_bib0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/msj.21300","article-title":"Recurrent hepatitis C after liver transplantation","volume":"79","author":"Sheiner","year":"2012","journal-title":"Mount Sinai J Med"},{"key":"10.1016\/j.clinre.2021.101714_bib0030","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2021.101714_bib0035","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","article-title":"Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis","volume":"64","author":"Foster","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2021.101714_bib0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12072-018-9914-6","article-title":"Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real \u2013 life cohort (Liver Network Activity - LINA cohort)","volume":"13","author":"Gentile","year":"2019","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.clinre.2021.101714_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2014.09.023","article-title":"Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study","volume":"148","author":"Curry","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinre.2021.101714_bib0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5604\/01.3001.0009.8592","article-title":"Persistence of virologic response after liver transplant in hepatitis C patients treated with ledipasvir \/ sofosbuvir plus ribavirin pretransplant","volume":"16","author":"Yoshida","year":"2017","journal-title":"Annals Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2021.101714_bib0055","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/tri.12568","article-title":"Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation","volume":"28","author":"Fortune","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.clinre.2021.101714_bib0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2016.05.010","article-title":"Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study","volume":"65","author":"Belli","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2021.101714_bib0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5604\/01.3001.0011.7388","article-title":"Sofosbuvir-based therapy in the pre-liver transplant setting: the Canadian National Experience","volume":"17","author":"Al-Judaibi","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinre.2021.101714_bib0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2021.101714_bib0075","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/liv.13629","article-title":"Follow-up of sustained virologic responders with hepatitis C and advanced liver disease after interferon\/ribavirin-free treatment","volume":"38","author":"Kozbial","year":"2018","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clinre.2021.101714_bib0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MEG.0000000000001250","article-title":"Impact of new direct-acting antiviral drugs on hepatitis C virus-related decompensated liver cirrhosis","volume":"31","author":"Essa","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2021.101714_bib0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/liv.13618","article-title":"Impact of hepatitis C (HCV) antiviral treatment on the need for liver transplantation","volume":"38","author":"Saez-Gonzalez","year":"2018","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.clinre.2021.101714_bib0090","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hep.28923","article-title":"Reduction in liver transplant wait-listing in the era of direct acting anti-viral therapy","volume":"65","author":"Flemming","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101714_bib0095","first-page":"257A","article-title":"Improving liver function and delisting of patients awaiting liver transplantation for HCV cirrhosis: do we ask too much to DAAs?","volume":"62","author":"Coilly","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinre.2021.101714_bib0100","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jhep.2017.08.008","article-title":"Clinical outcomes of undergoing antiviral therapy while awaiting liver transplantation","volume":"67","author":"Pascasio","year":"2017","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2021.101714_bib0105","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/liv.13878","article-title":"Delisting HCV infected transplant candidates who improved after viral eradication: outcome 2 years after delisting","volume":"38","author":"Perricone","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2021.101714_bib0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29054","article-title":"The dynamic landscape of liver transplant in the era of effective hepatitis C virus therapy","volume":"65","author":"Verna","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2021.101714_bib0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cld.2016.12.012","article-title":"The new era of hepatitis C therapy in liver transplant recipient","volume":"21","author":"Little","year":"2017","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2021.101714_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendation on treatment of hepatitis C 2018","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2021.101714_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhep.2018.03.009","article-title":"Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study","volume":"69","author":"Romano","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2021.101714_bib0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15825\/1995-1191-2019-2-7-15","article-title":"Organ donation and transplantation in Russian Federation in 2018 (11th report of the National Registry)","volume":"21","author":"Gautier","year":"2019","journal-title":"Russ J Transpl Artif Organs"},{"key":"10.1016\/j.clinre.2021.101714_bib0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.gastro.2018.04.008","article-title":"Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents","volume":"155","author":"Calvaruso","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinre.2021.101714_bib0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hep.29408","article-title":"Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease","volume":"69","author":"Backus","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101714_bib0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1478-3231.2005.01181.x","article-title":"Probability of liver cancer and survival in HCV \u2013 related or alcoholic \u2013 decompensated cirrhosis. A study of 377 patients","volume":"26","author":"Sola","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2021.101714_bib0150","first-page":"1","article-title":"Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the pre-direct \u2013 acting antiviral era","author":"McDonald","year":"2016","journal-title":"J Viral Hepat"},{"issue":"6","key":"10.1016\/j.clinre.2021.101714_bib0155","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/lt.24973","article-title":"Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States","volume":"24","author":"Kwong","year":"2018","journal-title":"Liver Transpl"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:32:39Z","timestamp":1761895959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740121000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2210740121000930"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101714","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101714"}}